Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RLAY

Relay Therapeutics, Inc.

CIK 0001812364 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$20.75
↑ 1.12 (5.71%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap
$3.98B
P/E Ratio
-14.58
EPS
-1.61
Dividend Yield
Not covered
52W Position
100%
Beta
1.75

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
6.19
P/S
372.37
EV/Revenue
353.21
ROE
-42.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 100%
$3.02$20.79

Latest Financials

2025-12-31 FY
Revenue
$15.36M
Net Income
-$276.48M
Total Assets
$621.33M
Free Cash Flow
-$235.87M

Recent news